Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Marcus Maurer, MD"'
Autor:
Thomas B. Casale, MD, Benjamin Trzaskoma, MS, Michael Holden, MD, Jonathan A. Bernstein, MD, Marcus Maurer, MD
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 8, Pp 100943- (2024)
The presence of angioedema, or deep skin swelling, in addition to hives (wheals) in patients with chronic spontaneous urticaria (CSU) can complicate disease management. There is evidence that omalizumab is effective for patients with CSU with angioed
Externí odkaz:
https://doaj.org/article/37ec73a1f4e641de8d5f4e7ac781d181
Autor:
Hugo W.F. Mak, MBBS, MRes(Med), Elaine Lee, MSc, Jane C.Y. Wong, MBBS, Karsten Weller, MD, Marcus Maurer, MD, Philip H. Li, MD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 3, Pp 100290- (2024)
Background: Uncontrolled chronic urticaria (CU) can severely affect physical and psychosocial health as well as quality of life. Patient-reported outcome measures are crucial for measuring disease control. The Urticaria Control Test (UCT) is recommen
Externí odkaz:
https://doaj.org/article/6e16af2aa3d24f4ab19ab8b7345511c7
Autor:
Hugo W.F. Mak, MBBS, Jane C.Y. Wong, MBBS, Sophia W.M. So, MBBS, Dorothy L.Y. Lam, MSc, Karsten Weller, MD, Marcus Maurer, MD, Philip H. Li, MBBS, MD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 4, Pp 100295- (2024)
Background: The impact of recurrent angioedema can be severely debilitating and remains difficult to quantify. Several standardized patient-reported outcome measures (PROMs), including the Angioedema Activity Score (AAS), Angioedema Quality of Life (
Externí odkaz:
https://doaj.org/article/8e6c2b725e5c45b5a287da7b80f5e924
Autor:
Christine J. Rubeiz, MD, Ricardo Asero, MD, Stephen Betschel, HBSc, MD, FRCP (C), Timothy Craig, DO, Anete Grumach, MD, PhD, Michihiro Hide, MD, PhD, David Lang, MD, Michael Levin, MD, PhD, Hilary Longhurst, MA, PhD, FRACP, FRCPath, Eli Magan, MD, Marcus Maurer, MD, Romi Saini, MD, Gordon Sussman, MD, Elias Toubi, MD, Dinh Nguyen Van, MD, PhD, Torsten Zuberier, MD, Jonathan A. Bernstein, MD
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 1, Pp 100858- (2024)
Background: Chronic spontaneous urticaria (CSU) is a common condition treated by allergist/immunologists, but the only FDA-approved biologic medication, omalizumab, may be underutilized globally. Objective: This study was performed to determine the g
Externí odkaz:
https://doaj.org/article/eb85b9cce00744179a1e04d894fc8c52
Autor:
Polina Pyatilova, MD, Jonathan A. Bernstein, MD, Felix Aulenbacher, Msc, Mario Sanchez Borges, MD, Saša Dimitrijević, PhD, Gerard Hoehn, PhD, Marcus Maurer, MD, Pavel Kolkhir, MD, Frank Siebenhaar, MD
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 11, Pp 100838- (2023)
Objective: Mastocytosis is a complex disorder affecting various organs. The diagnostic workup can be challenging and requires a multidisciplinary approach including the use of uncommon tests. To assess mastocytosis management around the globe, we con
Externí odkaz:
https://doaj.org/article/a469e1fdb3c5465f849855732a2708de
Publikováno v:
JAAD Case Reports, Vol 32, Iss , Pp 109-112 (2023)
Externí odkaz:
https://doaj.org/article/f540d11852854cfcafc98be4b648d249
Autor:
Xiaoman Du, MD, Yudi Chen, MD, Jianmin Chang, MD, Xuelin Sun, MD, PhD, Yue Zhang, MS, Meng Zhang, BM, Marcus Maurer, MD, PhD, Yanming Li, MD, Zuotao Zhao, MD, PhD, Xunliang Tong, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 29, Iss , Pp 106-109 (2022)
Externí odkaz:
https://doaj.org/article/7e64d60b09964bad8b37dea7df2f7c84
Autor:
Marcus Maurer, MD, Mohamed Abuzakouk, MD, PhD, Mona Al-Ahmad, MD, Waleed Al-Herz, MD, Hassan Alrayes, MD, Salem Al-Tamemi, MD, Rand Arnaout, MD, Hend Binghadeer, MD, Ravi Gutta, MD, Carla Irani, MD, Hassan Mobayed, MD, Iman Nasr, MD, Hiba Shendi, MD, Fares Zaitoun, MD, FACAAI
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 1, Pp 100729- (2023)
Background: Hereditary angioedema (HAE), a potentially life-threatening genetic disorder due to C1 inhibitor deficiency in most cases, is characterized by sudden and/or recurrent attacks of angioedema (subcutaneous/submucosal swellings). The global W
Externí odkaz:
https://doaj.org/article/efa1f2180e4a494e808a377acc3a7073
Autor:
Martin Metz, MD, Jonathan A. Bernstein, MD, Ana M. Giménez-Arnau, MD, PhD, Michihiro Hide, MD, PhD, Marcus Maurer, MD, Karl Sitz, MD, Weily Soong, MD, Gordon Sussman, MD, Eva Hua, MSc, Avantika Barve, PhD, Nathalie Barbier, MSc, Maria-Magdalena Balp, MD, Thomas Severin, MD
Publikováno v:
World Allergy Organization Journal, Vol 15, Iss 11, Pp 100716- (2022)
Background: Disease burden is particularly high in Chronic Spontaneous Urticaria (CSU) patients with angioedema, and patients whose signs and symptoms are inadequately controlled by H1-antihistamines need new treatment options. Here we report an expl
Externí odkaz:
https://doaj.org/article/a5accb64ff364949badf84c3169fe9b9
Autor:
Zenon Brzoza, MD, PhD, Karina Badura-Brzoza, MD, PhD, Marcus Maurer, MD, Tomasz Hawro, MD, Karsten Weller, MD
Publikováno v:
World Allergy Organization Journal, Vol 15, Iss 3, Pp 100635- (2022)
Background: Monitoring the effects of treatment on disease activity, impact, and control in patients with chronic spontaneous urticaria (CSU) is essential. We do not have enough information on how these features of CSU and its response to treatment a
Externí odkaz:
https://doaj.org/article/3347feeac9fb4cbe92e1b5c4de7202b8